Skip to main content

Conjugate Vaccines Market Professional Study Report 2020 by Types and Applications Forecast 2023

Conjugate Vaccines Market Overview
Conjugate vaccines are vaccines containing two antigens, one strong and one weak. The stronger antigen is generally made from proteins and is attached to a weaker polysaccharide antigen to form conjugate vaccines. Conjugate vaccines are used to counter diseases whose associated pathogens do not elicit a significant response from the human immune system on their own. As a result, a stronger antigen is attached to the weaker pathogen to make it more prominent and to elicit a stronger response from the immune system. The first conjugate vaccine was developed in response to the outbreak of meningitis, which still remains among the top targeted diseases in the conjugate vaccines market.
The global conjugate vaccines market is expected to exhibit a robust 10.5% CAGR over the forecast period, according to MRFR.
The growing government support for mass-scale vaccinations for disease eradication is likely to remain the prime driver for the global conjugate vaccines market over the forecast period. Considerable growth in vaccine development efforts from major market players is likely to be a major driver for the conjugate vaccines market over the forecast period.
Vaccination has taken on a key role in eliminating diseases such as meningitis, which can become a serious health problem given the right conditions. The growing support for further advancement in vaccine research and development is also likely to be a major driver for the global conjugate vaccines market over the forecast period.
Industry Key Players
Leading players in the global conjugate vaccine market includes,
  • GSK plc
  • Fablife
  • Sanofi Pasteur SA
  • Sinovac Biotech Ltd.
  • GreenSignal Bio Pharma Limited
  • Bavarian Nordic
  • Taj Pharmaceuticals Limited
  • IDT Biologics
  • Pfizer
  • SutroVax Inc.
  • and Merck & Co. Inc.
Market Segmentation
The global conjugate vaccine market is segmented on the basis of type, indication, end user, and region.
On the basis of type, the global conjugate vaccine market is segmented into haemophilus B, monovalent, multivalent, and others.
On the basis of indication, the conjugate vaccines market is segmented into influenza, pneumococcal, meningococcal, and others. Influenza dominates the global conjugate vaccines market with a 35% share, however, pneumococcal and meningococcal vaccines are also likely to take up a considerable share of the global conjugate vaccines market over the forecast period.
On the basis of end users, the market is segmented into pediatrics and adults.
The report studies the global conjugate vaccines market’s historical growth trajectory in order to provide pointers as to the major drivers and restraints affecting the market’s growth prospects and derive market growth markers that can indicate the market’s future growth trajectory over the forecast period from 2017 to 2023.
Access the Full Detailed Copy of This Report at https://www.marketresearchfuture.com/reports/conjugate-vaccine-market-4387
Detailed Regional Analysis
The global conjugate vaccines market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global conjugate vaccines market due to the growing demand for wide-scale disease eradication through vaccines and the growing vaccine research environment in advanced countries such as the U.S. and Canada. The growing government support to vaccination and vaccine development in this region, along with the presence of a strong and advanced biotechnology sector in the region, is also likely to be a major driver for the conjugate vaccines market over the forecast period.
Europe follows the Americas region in terms of its share in the global conjugate vaccines market and is likely to remain in a leading position through the forecast period due to the growing awareness about vaccines in Europe and the growing demand for developing cost-efficient, effective formulations of vaccines. The strong presence of the medical biotechnology sector in the region is also likely to be a major driver for the conjugate vaccines market in Europe.
Asia Pacific follows Europe in the global conjugate vaccines market and is likely to hold a reasonable share in the global market over the forecast period due to the growing awareness about the importance of vaccination in countries such as China and India. The growing population of this region is likely to drive the conjugate vaccines market in Asia Pacific over the forecast period.
About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

hyperpigmentation disorders treatment Overview

hyperpigmentation disorders treatment Analysis Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 Segmentation of The global h yperpigmentation disorders treatment market Segments  has been segmented based on treatment type, dise...
Post a Comment
Read more

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more